FUTIBATINIB | FUTIBATINIB | ATC L01EN04
ANTINEOPLASTIC FGFR2 1, 2 AND 3 KINASE COVALENT INHIBITOR (IC50 VALUES OF LESS THAN 4 NANOMOLAR) TREATMENT OF INTRAHEPATIC CHOLANGIOCARCINOMA
| ORAL | Cmax 344 NANOMOLAR Tmax 2 HOUR VD 66 LITER PPB 95 PERCENT Cl 20 LITER / HOUR HT 2.9 HOUR SOLUBILITY INSOLUBLE IN WATER | FIBROBLAST GROWTH FACTOR RECEPTOR 2 (FGFR2) FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FGFR1) FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) PDB 7D5O (C-SRC IN COMPLEX WITH TAS-120) LIGAND CODE = TZ0 (link to the list of PDB complexes) Download experimental 3D coordinates of TZ0 with added hydrogens | Fibroblast growth factor receptor 1 UNIPROT P11362 FGFR1 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |